20:47 Wed 07 Aug 2019
Feedback PLC - Statement re Online Commentary
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via
Statement re Online Commentary
The Company confirms that, in order to develop BleepaTM, the Company's clinical messaging product, it is currently working on completing a placing of new shares. There can be no certainty that such fundraising will be concluded nor as to the timing or terms of such, but a further announcement will be made as required as soon as possible.
-Ends-
Enquiries:
|
+44 (0)1954 718072 |
|
+44 (0)20 3328 5656 |
|
+44 (0)20 7469 0936 |
|
+44 20 3815 8880
+44 (0)20 7457 2020 |
Notes to editors
About
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE